Author: van den Bemt P.M.L.A.
Publisher: Adis International
ISSN: 0114-5916
Source: Drug Safety, Vol.25, Iss.2, 2002-01, pp. : 135-143
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
A Pharmacy-Based Health Promotion Programme in Hypertension: Cost-Benefit Analysis
By Côté I.
PharmacoEconomics, Vol. 21, Iss. 6, 2003-01 ,pp. :
Cost-Benefit Analysis of Amtolmetin-Guacil
Clinical Drug Investigation, Vol. 21, Iss. 1, 2001-01 ,pp. :